Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia
NCT ID: NCT00579059
Last Updated: 2017-07-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
31 participants
INTERVENTIONAL
2004-05-31
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of a Metal Backed Fixed-Bearing Tibial Baseplate and an All-Polyethylene Tibia in Total Knee Arthroplasty
NCT00979147
A Prospective, Randomized, Controlled Study Comparing Three Tibial Component Designs in Total Knee Arthoplasty
NCT00589147
Comparison of A Mobile-Bearing Total Knee System With A Fixed-Bearing Total Knee System In Cemented Total Knee Arthroplasty
NCT00589108
Post Market Clinical Follow-Up Study for MicroPort PROFEMUR® Preserve Classic Femoral Stem
NCT04615039
Prospective Trial of the TriFit™ Web Knee Brace
NCT03633071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
FDA has cleared these devices via Premarket Notification 510(k)'s K991753, K984623, K993159, K010027. The data gathered will be collated and used to provide feedback to designing engineers, support marketing efforts and answer potential questions from reimbursement agencies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Maxim® Pop-Top® Tibia
Maxim® Knee System with Removable Molded Polyethylene Tibia
Used for total knee replacements
2
Maxim® Regular Tibia
Regular Maxim® Knee System
Used for total knee replacements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Maxim® Knee System with Removable Molded Polyethylene Tibia
Used for total knee replacements
Regular Maxim® Knee System
Used for total knee replacements
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
K984623, K993159, K010027). These indications are stated below:
* Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
* Correction of varus, valgus, or posttraumatic deformity.
* Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure.
Patient selection factors to be considered include:
* need to obtain pain relief and improve function,
* ability and willingness of the patient to follow instructions, including control of weight and activity level,
* a good nutritional state of the patient,
* the patient must have reached full skeletal maturity.
* Porous coated knee joint replacement prostheses have not been approved for non-cemented applications in the United States.
Exclusion Criteria
Absolute contraindications include:
* infection,
* sepsis
* osteomyelitis.
Relative contraindications include:
* uncooperative patient or patient with neurologic disorders who are incapable of following directions,
* Osteoporosis,
* metabolic disorders which may impair bone formation,
* osteomalacia,
* distant foci of infections which may spread to the implant site,
* rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
* vascular insufficiency, muscular atrophy, neuromuscular disease,
* incomplete or deficient soft tissue surrounding the knee.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biomet Orthopedics, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Russell Wagner, MD
Role: PRINCIPAL_INVESTIGATOR
Harris Methodist Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biomet Orthopedics, LLC
Warsaw, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
62-U-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.